CHEManager International is the premier brand for the chemical, pharmaceutical, and biotech industries. It empowers managers and executives with a competitive edge through timely business news, expert insights, and the latest market data, enabling strategic business and investment decisions.
Samsung Biologics, a global contract development and manufacturing organization (CDMO), recently announced a series of manufacturing deals with a Europe-based pharmaceutical company.
The CHEManager Innovation Pitch is both a showcase and a competition for start-ups in the chemical industry. Each year, industry experts select a winning start-up from the finalists.
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
Strategic Value Partners (SVP) and Blantyre Capital Limited (Blantyre) recently announced the acquisition of OQ Chemicals (Oxea), a leading global producer and merchant of oxo chemicals.
Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.
